论文部分内容阅读
我国加入世界贸易组织,给医药行业的发展带来了良好的机遇,同时也带来了一定的挑战。要在“十五”期间顺利实施医药经济双倍增计划,使江苏省早日发展成为医药经济强省,必须对医药行业发展中的若干问题进行深入的研究。省政协原副主席沙人麟及中国药科大学有关专家、学者组成专题课题组,用一年多的时间,在广泛查阅国内外资料、赴有关企事业单位实地调研、征询专家意见的基础上,撰写了《关于江苏省当前医药行业的发展及其有关问题的若干建议》,报省政府领导同志参阅。省长梁保华、副省长李全林对《建议》作出批示予以肯定。本刊分三期连续刊登此文,以飨读者。
China’s accession to the World Trade Organization has brought about good opportunities for the development of the pharmaceutical industry and brought certain challenges. To smoothly implement the double-digit medical economic expansion plan during the “10th Five-Year Plan” period, and to make Jiangsu Province as soon as possible develop into a strong province of medicine and economy, it is necessary to conduct in-depth research on several issues in the development of the pharmaceutical industry. The former Vice Chairman of the Provincial People’s Political Consultative Conference Sha Renlin and experts and scholars of the China Pharmaceutical University organized a topical task force that spent more than one year reviewing domestic and foreign data, conducting on-site research and consulting with relevant experts and institutions, and consulting experts. He wrote “Some Suggestions on the Development of the Pharmaceutical Industry in Jiangsu Province and Related Issues,” and referred to the leaders of the provincial government. Governor Liang Baohua and Deputy Governor Li Quanlin affirmed the “Proposal.” This issue is published in three consecutive installments of this article for readers.